Rankings
▼
Calendar
CGEM FY 2020 Earnings — Cullinan Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
CGEM
Cullinan Therapeutics, Inc.
$841M
FY 2020 Earnings
Healthcare
Medical - Pharmaceuticals
Income Statement
Revenue
$0
Gross Profit
-$62,000
Operating Income
-$60M
Net Income
-$52M
EPS (Diluted)
$-1.19
Cash Flow
Operating Cash Flow
-$30M
Free Cash Flow
-$30M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$215M
Total Liabilities
$14M
Stockholders' Equity
$199M
Cash & Equivalents
$168M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$62,000
-$70,000
+11.4%
Operating Income
-$60M
-$22M
-170.9%
Net Income
-$52M
-$20M
-158.5%
← Q4 2019
All Quarters
Q1 2020 →